Connection

Shiv Sarin to Antiviral Agents

Back to Details
This is a "connection" page, showing publications Shiv Sarin has written about Antiviral Agents.
Shiv Sarin
Connection Strength
0.177
Antiviral Agents
  1. Generic sofosbuvir-based direct-acting antivirals in hepatitis C virus-infected patients with chronic kidney disease. Liver Int. 2018 12; 38(12):2137-2148.
    View in: PubMed
    Score: 0.071
  2. Management protocols for hepatitis B. Indian J Gastroenterol. 2001 Mar; 20 Suppl 1:C52-4.
    View in: PubMed
    Score: 0.021
  3. APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation. Hepatol Int. 2019 Nov; 13(6):649-661.
    View in: PubMed
    Score: 0.019
  4. A randomized open label trial of tenofovir monotherapy versus tenofovir plus telbivudine in spontaneous reactivation of hepatitis B. Saudi J Gastroenterol. 2019 Sep-Oct; 25(5):319-326.
    View in: PubMed
    Score: 0.019
  5. APASL clinical practice recommendation: how to treat HCV-infected patients with renal impairment? Hepatol Int. 2019 Mar; 13(2):103-109.
    View in: PubMed
    Score: 0.018
  6. Peg-interferon plus nucleotide analogue in patients with chronic hepatitis B with low viral load. Lancet Gastroenterol Hepatol. 2017 09; 2(9):628.
    View in: PubMed
    Score: 0.017
  7. Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure. Hepatology. 2011 Mar; 53(3):774-80.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.